Live Mass Tort Intelligence
FDA safety alerts, MAUDE adverse-event reports, EPA enforcement actions, federal court dockets, product recalls, and scientific literature — continuously monitored and unified into one litigation intelligence feed.
48
Torts Monitored
41
With Recent Activity
465
Activity This Week
68
Sources Tracked
Daily Intelligence Brief
August 12, 2026
Hair Relaxer Leads a Firm-Concentrated Docket
Hair-relaxer claims set the day’s pace as Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (3060) drew 17 filings, with Pulaski Kherkher PLLC filing seven and Wallace Miller four. Platform litigation held the next tier: Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) added 10 cases, six from Levin Papantonio and one from Bossier & Associates PLLC. Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability (Gastroparesis) Litigation (3094) received nine complaints, five through Nigh Goldenberg Raso Vaughn PLLC and one through Hammers Law Firm LLC, extending the drug docket’s steady intake. PFAS and device claims each added seven cases, as Aqueous Film-Forming Foams Personal Injury Products Liability Litigation (2873) drew four filings from Keefe Law Firm LLC and one from The Law Firm of Hutchens Senter & Britton PA, while every new Covidien Hernia Mesh Products Liability Litigation (No. II) (3029) complaint came from Babin Law LLC. See the full filing feed and firm-level breakdowns here.
Ninth Circuit Keeps Social-Media Addiction Claims Alive
The Ninth Circuit on August 10 dismissed Meta’s and TikTok’s interlocutory appeals as premature, rejecting their bid to use a Section 230 defense to halt claims at the threshold in Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047). The ruling keeps more than 3,000 federal cases in the district court rather than allowing the defendants to convert an asserted liability defense into immediate appellate immunity. It does not decide whether any platform caused injury or owes damages, but it preserves the plaintiffs’ route to merits litigation. That procedural loss increases pressure on defendants to litigate the design, recommendation, notification and engagement evidence that their appeals sought to avoid.
California Social-Media Trial Moves to Jury Selection
Jury selection begins August 12 in California’s action against Meta, with opening statements scheduled for August 18, bringing Social Media Adolescent Addiction Personal Injury Products Liability Litigation (3047) to an immediate trial-stage test. The proceeding uses an advisory jury, leaving Judge Yvonne Gonzalez Rogers with ultimate authority over factual findings rather than delivering a conventional binding verdict. The schedule forces the parties to present their competing evidence on youth harm and platform design now, not after another round of threshold briefing. Its result will not resolve the full federal docket, but the evidence record and judicial findings will become an important measure of leverage as the broader litigation advances.
Analyst Workbench
Track litigations for free — sign in to get started.
Save matters, capture notes, and monitor live signals — sign in to get started.
Featured Dockets
Medical device
MDL 3081 (D. Ariz.) case management orders, bellwether selection, Becton Dickinson design-defect rulings, and catheter fracture adverse-event reports
Medical device
MDL 3125 (S.D. Cal., Judge Jinsook Ohta) case management orders, bellwether selection, AngioDynamics/Navilyst design-defect rulings, and port catheter adverse-event reports
Medical device
MDL 3181 docket activity, MAUDE adverse-event reports, device recall activity, and bellwether scheduling
Environmental exposure
MDL 3040 drinking-water bellwether trials, EPA PFAS MCL rulemaking, state remediation suits, and Chemours/DuPont liability developments
Product liability
MDL 3108 proceedings in the Eastern District of New York, FDA final guidance on heavy metals in baby foods, and state-level class action filings
Institutional abuse
BSA bankruptcy trust (D. Del.) claims processing and distribution orders, state lookback window filings, local council contribution disputes, and Hartford and Century indemnity proceedings
Toxic exposure
Cook County and Gwinnett/Cobb County state toxic-tort verdicts and settlements, EPA fenceline monitoring rule implementation, Sterigenics and Becton Dickinson site-specific rulings, and IARC/EPA carcinogenicity updates
Institutional abuse
State civil abuse suits against LDS Church entities, clergy-penitent privilege rulings in Utah and other jurisdictions, state lookback window legislation, and church mandatory-reporting reform activity
Consumer / platform liability
Individual and class action filings against Activision, Epic, and Roblox alleging addictive game design, JPML consolidation petitions, FTC and state AG enforcement actions, and DSM gaming disorder clinical research
Consumer tech / product liability
P.J. v. Character Technologies (N.D.N.Y. 1:25-cv-01295) and Gavalas v. Google (N.D. Cal. 5:26-cv-01849) docket activity, JPML consolidation petitions, FTC AI safety enforcement actions, and suicide-contagion and chatbot-harm clinical research
Litigation Dashboard
| Tort | Category | Trend | Activity Status | LexGenius Ranking | |
|---|---|---|---|---|---|
| PowerPort | Medical device | — | EXPANDING | 100Activity | |
| AngioDynamics Port | Medical device | — | OPEN | 100Activity | |
| Boston Sci. SCS | Medical device | — | OPEN | 98Activity | |
| PFAS | Environmental exposure | — | OPEN | 96Activity | |
| Covidien Hernia Mesh | Medical device | — | OPEN | 96Activity | |
| Bard Hernia Mesh | Medical device | — | OPEN | 95Activity | |
| Depo-Provera | Pharmaceutical | — | EXPANDING | 92Activity | |
| Suboxone Teeth | Pharmaceutical | — | OPEN | 92Activity | |
| Ozempic Gastroparesis | Pharmaceutical | — | OPEN | 92Activity | |
| Ozempic NAION | Pharmaceutical | — | OPEN | 92Activity | |
| Tylenol | Pharmaceutical | — | OPEN | 92Activity | |
| Zantac | Pharmaceutical | — | OPEN | 92Activity | |
| Nevro SCS | Medical device | — | EXPANDING | 90Activity | |
| Talc | Product liability | — | OPEN | 88Activity | |
| Paragard | Medical device | — | MONITORING | 88Activity | |
| Dupixent CTCL | Pharmaceutical | — | OPEN | 88Activity | |
| Cartiva | Medical device | — | OPEN | 88Activity | |
| AFFF | Toxic exposure | — | OPEN | 86Activity | |
| Roundup | Product liability | — | OPEN | 84Activity | |
| Paraquat | Product liability | — | OPEN | 84Activity | |
| NEC Formula | Medical nutrition | — | OPEN | 82Activity | |
| Social Media | Platform liability | — | OPEN | 82Activity | |
| Abbott SCS | Medical device | — | EXPANDING | 82Activity | |
| Hair Relaxer | Product liability | — | OPEN | 79Activity | |
| Camp Lejeune | Toxic exposure | — | OPEN | 76Activity | |
| Uber Assault | Negligence / survivor litigation | — | OPEN | 76Activity | |
| Discord Abuse | Consumer tech / product liability | — | EXPANDING | 75Activity | |
| Lyft Assault | Negligence / survivor litigation | — | OPEN | 73Activity | |
| Roblox | Consumer / platform liability | — | OPEN | 73Activity | |
| Cyclosporiasis Outbreak | Product liability | — | EXPANDING | 70Activity | |
| ByHeart Formula | Product liability | — | EXPANDING | 70Activity | |
| Baby Food Metals | Product liability | — | OPEN | 67Active Watch | |
| Boy Scouts | Institutional abuse | — | MONITORING | 62Active Watch | |
| Church Abuse | Institutional abuse | — | OPEN | 56Active Watch | |
| Social Media Sextortion | Consumer / platform liability | — | EXPANDING | 52Active Watch | |
| EtO Sterilization | Toxic exposure | — | MONITORING | 48Moderate Activity | |
| LDS Abuse | Institutional abuse | — | MONITORING | 48Moderate Activity | |
| Video Game Addiction | Consumer / platform liability | — | EXPANDING | 46Moderate Activity | |
| AI Chatbot Harm | Consumer tech / product liability | — | OPEN | 46Moderate Activity | |
| Benzene Litigation | Toxic exposure | — | EXPANDING | 46Moderate Activity | |
| UPF Litigation | Product liability | — | EXPANDING | 46Moderate Activity | |
| Hotel Trafficking | Survivor litigation | — | MONITORING | 44Moderate Activity | |
| Sports Betting | Consumer / platform liability | — | EXPANDING | 44Moderate Activity | |
| Oxbryta | Pharmaceutical | — | MONITORING | 42Moderate Activity | |
| Keytruda | Pharmaceutical | — | EXPANDING | 40Moderate Activity | |
| 1,4-Dioxane | Environmental exposure | — | MONITORING | 38Moderate Activity | |
| CA Women's Prisons | Civil rights / institutional harm | — | MONITORING | 36Moderate Activity | |
| Assembly of God | Institutional abuse | — | MONITORING | 34Moderate Activity |